文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

BIO 300(染料木黄酮纳米混悬液)减轻放射性勃起功能障碍并保持前列腺癌放疗敏感性

BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-06-05

该临床前研究评估合成染料木黄酮纳米混悬液BIO 300能否在不降低肿瘤放射敏感性的前提下预防放射性勃起功能障碍(ED)。大鼠前列腺局部照射25 Gy后,放疗前3天开始每日给予BIO 300可维持勃起频率与假照射组相似,且未影响前列腺癌移植瘤的放疗后生长延迟。结果提示BIO 300有临床转化潜力。

要点

  • 前列腺局部25 Gy照射显著降低大鼠阿扑吗啡诱导的勃起反应。
  • 放疗前3天起每日BIO 300可维持勃起频率至假照射组水平。
  • BIO 300未削弱激素敏感及不敏感前列腺癌移植瘤的放疗效果。

核心结论

  • BIO 300在放疗前3天开始并持续每日给药至14周可预防放射性ED,且不降低前列腺癌移植瘤的放疗反应。

研究设计与样本

  • 雄性Sprague-Dawley大鼠接受25 Gy 220-kV前列腺局部X线照射,随机分为假放疗、单纯放疗、放疗联合每日BIO 300两种实验剂量方案、放疗联合每日染料木黄酮。
  • 采用前列腺癌细胞系小鼠移植瘤研究评估BIO 300给药对放疗疗效的影响。

主要发现

  • 前列腺局部放疗显著降低阿扑吗啡诱导的勃起反应(P < .05,对比假放疗)。
  • 放疗前3天开始预防性BIO 300治疗的大鼠,放疗后勃起频率与假照射对照相似。
  • 合成染料木黄酮未能减轻勃起频率下降。
  • 放疗后第14周,BIO 300治疗后勃起功能质量显著高于单纯放疗组及放疗前3天开始染料木黄酮组(P < .05)。
  • 在激素敏感和激素不敏感前列腺肿瘤小鼠中,BIO 300给药未对放疗诱导的肿瘤生长延迟产生负面影响。

临床怎么用

  • 临床前证据支持BIO 300作为放射性ED预防策略进行临床转化,且可能不影响前列腺癌放疗疗效。
  • BIO 300在放疗前3天开始给药并持续至14周显示获益,放疗后2小时开始给药也可能减轻放射性ED。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whether BIO 300, a synthetic genistein nanosuspension, improves the therapeutic index in prostate cancer treatment by preventing radiation-induced erectile dysfunction (ED) without reducing tumor radiosensitivity. METHODS AND MATERIALS: Male Sprague-Dawley rats were exposed to 25 Gy of 220-kV prostate-confined x-rays. Animals were randomized to receive sham radiation therapy (RT), RT alone, RT with daily BIO 300 at 2 experimental dosing regimens, or RT with daily genistein. Erectile response was evaluated over time. Penile shaft tissue was harvested for histologic analyses. Murine xenograft studies using prostate cancer cell lines determined the effects of BIO 300 dosing on RT efficacy. RESULTS: Prostate-confined RT significantly decreased apomorphine-induced erectile response (P < .05 vs sham RT). Erection frequency in animals receiving prophylactic treatment with BIO 300 starting 3 days before RT was similar to sham controls after RT. Treatment with synthetic genistein did not mitigate loss in erectile frequency. At week 14, post-RT treatment with BIO 300 resulted in significantly higher quality of erectile function compared with both the RT arm and the RT arm receiving genistein starting 3 days before irradiation (P < .05). In hormone-sensitive and insensitive prostate tumor-bearing mice, BIO 300 administration did not negatively affect radiation-induced tumor growth delay. CONCLUSIONS: BIO 300 prevents radiation-induced ED, measured by erection frequency, erectile function, and erection quality, when administered 3 days before RT and continued daily for up to 14 weeks. Data also suggest that BIO 300 administered starting 2 hours after RT mitigates radiation-induced ED. Data provide strong nonclinical evidence to support clinical translation of BIO 300 for mitigation of ED while maintaining treatment response to RT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Jackson IL, Pavlovic R, Alexander AA, et al. BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31175904. doi:10.1016/j.ijrobp.2019.05.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。